EUVIMEDEUVIMED entdecken
Delphi-Studie

Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study

Adenike R Adelakun, Mary A De Vera, Kim McGrail, Ricky D Turgeon, Arden R Barry, Jason G Andrade, Jenny MacGillivray, Marc W Deyell, Leanne Kwan, Doson Chua, Elaine Lum, Reginald Smith und 1 weitere

Advances in Therapy · 2024

DOI: 10.1007/s12325-024-02859-0 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Advances in Therapy, 2024. Verfasst von Adenike R Adelakun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of British Columbia (UBC), Vancouver, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Delphi Technique, Anticoagulants. Die Arbeit nennt 46 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Patients with atrial fibrillation (AF) often switch between oral anticoagulants (OACs). It can be hard to know why a patient has switched outside of a clinical setting. Medication attribute comparisons can suggest benefits. Consensus on terms and definitions is required for inferring OAC switch benefits. The objectives of the study were to generate consensus on a taxonomy of the potential benefits of OAC switching in patients with AF and apply the taxonomy to real-world data. METHODS: Nine expert clinicians (seven clinical pharmacists, two cardiologists) with at least 3 years of clinical and research experience in AF participated in a Delphi process. The experts rated and commented on a proposed taxonomy on the potential benefits of OAC switching. After each Delphi round, ratings were analyzed with the RAND Corporation/University of California, Los Angeles (RAND/UCLA) appropriateness method. Median ratings, disagreement index, and comments were used to modify the taxonomy. The resulting taxonomy from the Delphi process was applied to a cohort of patients with AF who switched OACs in a population-based administrative health dataset from 1996 to 2019 in British Columbia, Canada. RESULTS: The taxonomy was finalized in two Delphi rounds, reaching consensus on five switch benefit categories: safety, effectiveness, convenience, economic considerations, and drug interactions. Safety benefit (a switch that could lower the risk of adverse drug events) had three subcategories: major bleeding, intracranial hemorrhage (ICH), and gastrointestinal (GI) bleeding. Effectiveness benefit had four subcategories: stroke and systemic embolism (SSE), ischemic stroke, myocardial infarction (MI), and all-cause mortality. Real-world OAC switches revealed that more OAC switches had convenience (72.6%) and drug interaction (63.0%) benefits compared to effectiveness (SSE 22.0%, ischemic stroke 11.1%, MI 3.1%, all-cause mortality 10.1%), safety (major bleeding 24.3%, GI bleeding 10.6%, ICH 48.5%), and economic benefits (12.1%). CONCLUSIONS: The Delphi-based taxonomy identified five criteria for the beneficial effects of OAC switching, aiding in characterizing real-world OAC switching.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationDelphi TechniqueAnticoagulantsHumansAdministration, OralFemaleMaleAgedDrug SubstitutionConsensusStrokeMiddle Aged

Stichwörter der Autor:innen

Atrial fibrillationBenefitsDelphiMedication switchOral anticoagulantsTaxonomy

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, University of British Columbia (UBC), Vancouver, Canada.
  • UBC Collaboration for Outcomes Research and Evaluation, Vancouver, Canada.
  • UBC School of Population and Public Health, Vancouver, Canada.
  • UBC Centre for Health Services and Policy Research, Vancouver, Canada.
  • Jim Pattison Outpatient Care and Surgery Centre, Surrey, Canada.
  • Vancouver General Hospital, Vancouver, Canada.

ORCID-Profile: Peter Loewen

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Adelakun, A. R., De Vera, M. A., McGrail, K., Turgeon, R. D., Barry, A. R., Andrade, J. G., MacGillivray, J., Deyell, M. W., Kwan, L., Chua, D., Lum, E., Smith, R., & Loewen, P. (2024). Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study. Advances in Therapy. https://doi.org/10.1007/s12325-024-02859-0

Vancouver

Adelakun AR, De Vera MA, McGrail K, Turgeon RD, Barry AR, Andrade JG, et al. Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study. Advances in Therapy. 2024. doi:10.1007/s12325-024-02859-0

BibTeX
@article{Adelakun2024,
  author = {Adelakun, Adenike R and De Vera, Mary A and McGrail, Kim and Turgeon, Ricky D and Barry, Arden R and Andrade, Jason G and MacGillivray, Jenny and Deyell, Marc W and Kwan, Leanne and Chua, Doson and Lum, Elaine and Smith, Reginald and Loewen, Peter},
  title = {Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study},
  journal = {Advances in Therapy},
  year = {2024},
  doi = {10.1007/s12325-024-02859-0}
}
Kostenlos starten →